旋切术治疗股浅动脉复杂病变的结局
12个月和24个月一期通畅率分别为75%和65%,2年大截肢率在严重肢体缺血患者中为3.9%,30天内无截肢,安全性良好。
要点
- 严重肢体缺血患者2年大截肢发生率为3.9%(95%CI 1.2%-6.5%)。
核心结论
- 旋切术联合药物涂层球囊成形术治疗长段股浅动脉病变具有优异长期通畅率。
- 2年大截肢率和死亡率低,该技术安全性极佳。
研究设计与样本
- 平均年龄70.2±9.8岁,73%男性,65%为严重肢体缺血,平均随访543天。
- 主要结局为Kaplan-Meier一期通畅率、免于大截肢率和2年生存率。
主要发现
- 平均病变长度13.2±9.0 cm,58%病变为TASC C或D级。
- 1个月随访时45例中39例(87%)症状和Rutherford分级改善。
- 12个月一期通畅率75%(95%CI 61%-85%),24个月65%(95%CI 51%-77%)。
- 2年死亡率药物涂层球囊组11% vs 普通球囊组0%,无显著差异。
关键数值与推荐
- 严重肢体缺血患者2年大截肢发生率为3.9%(95%CI 1.2%-6.5%)。
- 30天内1例死亡,无截肢。
临床怎么用
- 对于长段股浅动脉复杂病变,可考虑旋切术联合药物涂层球囊成形术。
- 术后1个月踝肱指数和趾压显著改善并维持至18个月,可作为疗效监测指标。
- 严重肢体缺血患者2年大截肢率低,该技术安全可行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effectiveness of rotational atherectomy in the treatment of complex superficial femoral artery (SFA) lesions remains poorly defined. Outcomes of SFA lesions treated with rotational atherectomy were analyzed. METHODS: This retrospective review assessed all patients who underwent rotational atherectomy of the SFA at a single institution between 2015 and 2018. The data of all patients were deidentified, and the study was approved by the Institutional Review Board. Informed consent was not obtained for this retrospective analysis. Main outcomes were Kaplan-Meier primary patency rate, freedom from major amputation, and 2-year survival rate. The effect of drug-coated balloon angioplasty (DCBA) on patency and time to death was investigated with univariate regression. The safety profile for atherectomy and DCBA was assessed by the 30-day incidence of major amputation and all-cause mortality. RESULTS: Fifty-three patients (mean age, 70.2 ± 9.8 years; 73% male; 65% critical limb-threatening ischemia; 47 [90%] current or former smokers; seven [13%] with prior failed ipsilateral endovascular intervention) underwent rotational atherectomy (Jetstream; Boston Scientific, Marlborough, Mass) with mean follow-up of 543 days. Forty-six (87%) patients underwent DCBA (Lutonix; BD Bard, Covington, Ga) after atherectomy. Mean lesion length was 13.2 ± 9.0 cm. Thirty-one (58%) lesions were TransAtlantic Inter-Society Consensus C or D class. At 1-month follow-up, 39 of 45 (87%) patients experienced improvement in symptoms and Rutherford class. An improvement in ankle-brachial index was also noted in 13% of patients without improvement of symptoms, with no patients progressing to surgical bypass or major amputation. Mean ankle-brachial index increased from 0.54 ± 0.035 to 0.90 ± 0.031 at 1 month after intervention (P < .001) and remained constant out to 18 months. Mean toe pressure increased from 36 ± 3.8 mm Hg to 67 ± 4.5 mm Hg at 1 month after intervention (P < .001) and remained constant out to 18 months. Kaplan-Meier primary patency rate was 75% (95% confidence interval, 61%-85%) at 12 months and 65% (51%-77%) at 24 months. There was a trend toward improved primary patency after adjunctive DCBA compared with plain balloon angioplasty at 1 year (75% vs 43%; P = .1082). There was no significant difference in mortality between adjunctive DCBA and plain balloon angioplasty at 2 years (11% vs 0%). The 2-year incidence of major amputation in critical limb-threatening ischemia patients was 3.9% (1.2%-6.5%). One patient died and none underwent amputation within 30 days. CONCLUSIONS: Rotational atherectomy with adjunctive DCBA of long SFA lesions has excellent long-term patency. Two-year major amputation and mortality rates are low, and the technique has an exceptional safety profile.
引用
- Ponukumati AS, Suckow BD, Powell CJ, et al. Outcomes of rotational atherectomy in complex lesions of the superficial femoral artery. J Vasc Surg. 2020. PMID: 32325226. doi:10.1016/j.jvs.2020.03.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。